首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >Do You Want to Hear the Bad News? The Value of Diagnostic Tests for Alzheimer's Disease
【24h】

Do You Want to Hear the Bad News? The Value of Diagnostic Tests for Alzheimer's Disease

机译:Do You Want to Hear the Bad News? The Value of Diagnostic Tests for Alzheimer's Disease

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: The diagnosis of Alzheimer's disease (AD) remains difficult. Lack of diagnostic certainty or possible distress related to a positive result from diagnostic testing could limit the application of new testing technologies. The objective of this paper is to quantify respondents' preferences for obtaining AD diagnostic tests and to estimate the perceived value of AD test information. Methods: Discrete-choice experiment and contingent-valuation questions were administered to respondents in Germany and the United Kingdom. Choice data were analyzed by using random-parameters logit. A probit model characterized respondents who were not willing to take a test. Results: Most respondents indicated a positive value for AD diagnostic test information. Respondents who indicated an interest in testing preferred brain imaging without the use of radioactive markers. German respondents had relatively lower money equivalent values for test features compared with respondents in the United Kingdom. Conclusions: Respondents preferred less invasive diagnostic procedures and tests with higher accuracy and expressed a willingness to pay up to 700 to receive a less invasive test with the highest accuracy. (C) Copyright 2016, International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号